Last reviewed · How we verify

NCT01022268

Understanding Childhood Infection, Inflammation and Allergy

Completed Results posted Last updated 21 November 2022
What this trial tests

trial in Infection in 902 participants. Completed in 11 June 2019.

Timeline
20 July 2009
Primary endpoint
30 August 2018
11 June 2019

Quick facts

Lead sponsorImperial College London
StatusCompleted
Study typeOBSERVATIONAL
Enrollment902
Start date20 July 2009
Primary completion30 August 2018
Estimated completion11 June 2019
Sites1 location across United Kingdom

Conditions studied

Sponsor

Imperial College London

Who can join

Under 16, any sex, with Infection or Inflammation. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

What Are the Bacterial and Viral Causes of Acute Illness in Children Presenting to a UK General Hospital, Tertiary Paediatric Infectious Disease Unit and Paediatric Intensive Care Unit? Primary · Participants were monitored for outcome throughout their stay in hospital, and received follow-up review at 10 days

number of participants with phenotype of definite bacterial or definite viral disease, based on culture or molecular investigations of samples from a sterile site

GroupValue95% CI
Infection, Inflammation or Allergy123
Controls0
Infection, Inflammation or Allergy164
Controls0
Infection, Inflammation or Allergy41
Controls0
Infection, Inflammation or Allergy450
Controls0

Sponsor's own description

This proposal represents a unified programme supported by both clinical and academic staff in the Departments of Paediatrics at Imperial College and St Mary's Hospital, Southampton Hospital and John Radcliffe Hospital (Oxford). St Mary's Hospital is the hub of a paediatric network for West London, and forms part of the Paediatric Intensive Care Network for the London region, with potential access to a population of 3 million children. We aim to improve diagnosis and understanding of children with infectious, inflammatory and allergic conditions. Our study will establish well-characterised cohorts of patients with defined conditions, in whom microbiological and patient samples will be used to understand the contribution of genetic background, differential gene expression, proteomics and the pathogen type to the disease process. Unwell children coming to hospital through any route will be invited to join the study. Entering the study will entail the child having blood taken for research purposes in addition to the clinically indicated tests. We will also recruit well (control) children who are having blood tests performed for elective purposes, such as surgery. In addition, children presenting with an illness that is likely to have an infectious aetiology will also have samples collected for microbiological diagnosis. Those samples taken for ordinary diagnostic purposes (such as blood, urine, cerebrospinal fluid (CSF), bronchoalveolar lavage (BAL) fluid or nasal brushings for epithelial cell cultures) would also be used for state-of-the-art diagnostic techniques, in order to maximise the likelihood of confirming a microbiological diagnosis. Where healthy, uninfected children are having invasive procedures, such as lumbar punctures, we would aim to recruit these children as controls and collect biological samples such as CSF samples. This bid addresses the need for translational research in paediatrics, by building on the world-class basic science and clinical paediatric base at Imperial College and St Mary's Hospital.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Infection

Currently open trials in the same condition.

Other Imperial College London trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01022268.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing